Eva Steiness, MD, D.Sci. professor clinical pharmacology
Postgraduate 10 years at University Hospital in Aarhus, Jutland and Rigshospitalet in Copenhagen
Dean at Medical Faculty, Copenhagen University 1981-85. Professor clinical Pharmacology Aarhus University 1985-1989
Executive Vice President, Drug Discovery & Development Lundbeck Pharma A/S 1989-1999. Was a member of the Executive Board and instrumental in the pipeline development for the IPO in 1999. Today, Lundbeck Pharma A/S is a OMX C25 index member on the Copenhagen Stock Exchange
Founder and CEO of Zealand Pharma A/S 1999-2008. The company went public in 2010 and is today a C-25 index member on the Copenhagen Stock Exchange
CEO and co-founder of Phlogo ApS 2008-2013. Acquired by Serodus AS 2013
CEO of Serodus AS from 2013 to 2023 and present the CEO of Serodus ApS which manage and develops a pipeline focused on Diabetic Nephropathy
Mr Mordhorst holds an MSc in Economics from Copenhagen Business School, Denmark. Certified financial advisor UK/CH
30 years+ experience in finance, asset management and commercial real estate
Founder and CEO of HeMo ApS
Mr. Mordhorst joined Serodus in 2019 as consultant.
MSc Pharm (UCPH), Executive MBA (CBS), Diploma in Managing Medicinal Product Innovation (SIMI)
+25 years of life science experience primarily within Regulatory Operations, R&D Data & Digital Strategies
(Genmab, Ferring, LEO Pharma)
Founder and Managing Director of Documizer ApS – specializing in documentation of R&D science assets.
Mr. Capion joined Serodus in 2022 as consultant.